 Navin Fluorine International Ltd approves capex
Navin Fluorine International Ltd approves capex Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart
Purest gold, silver products in 10 minutes: MMTC-PAMP partners with Swiggy Instamart Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets
Cosmo Plastech Expands Rigid Packaging Solutions for the Pharmaceutical Industry with PET Sheets IPO Note - Lenskart Solutions Ltd - Reliance Securities
IPO Note - Lenskart Solutions Ltd - Reliance Securities IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025
IndiGo expands its Middle East footprint with new Bengaluru-Riyadh direct flights, starting 16 November 2025 
              The Operations Committee of the Board of Directors of Glenmark Pharmaceuticals Ltd, at its Meeting held on July 14, 2016 allotted 2,000 equity shares to the employee of the Company on exercise of options granted to them pursuant to ESOS 2003.
Shares of GLENMARK PHARMACEUTICALS LTD. was last trading in BSE at Rs.853.25 as compared to the previous close of Rs. 848.6. The total number of shares traded during the day was 40663 in over 1575 trades.
The stock hit an intraday high of Rs. 858 and intraday low of 846. The net turnover during the day was Rs. 34691922.